Evidence map›Paper›PMID 25712056›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2015

Nrf2-dependent suppression of azoxymethane/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde.

Min Long, Shasha Tao, Montserrat Rojo de la Vega, Tao Jiang, Qing Wen, Sophia L Park, Donna D Zhang, Georg T Wondrak

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Dual Role of NRF2 in Pancreatic Precursor Lesions.Cancer research communications · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. The role and mechanism of cinnamaldehyde in cancer.Journal of food and drug analysis · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Hepatoprotection ofVeterinary world · 2022
    Article
  17. Article
  18. NRF2: KEAPing Tumors Protected.Cancer discovery · 2022
    Article
  19. Article
  20. The intricacies of NRF2 regulation in cancer.Seminars in cancer biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Min LongDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona. Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing, P.R. China.
Shasha TaoDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona.
Montserrat Rojo de la VegaDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona.
Tao JiangDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona.
Qing WenDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona. Department of Pharmacy, Jinan Central Hospital, Shandong University, Shandong, P.R. China.
Sophia L ParkDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona.
Donna D ZhangDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona. wondrak@pharmacy.arizona.edu dzhang@pharmacy.arizona.edu.
Georg T WondrakDepartment of Pharmacology and Toxicology, College of Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, Arizona. wondrak@pharmacy.arizona.edu dzhang@pharmacy.arizona.edu.
University of Arizona · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicityR01ES015010 · NIEHS · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2006 to 2015
$3.4M
Investigation of an anti-cancer phytochemical targeting Nrf2R01CA154377 · NCI · UNIVERSITY OF ARIZONA · PI ZHANG, DONNA D · 2011 to 2015
$1.5M
Targeting colorectal carcinogenesis using a cinnamon-derived food factorR21CA166926 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T, ZHANG, DONNA D · 2013 to 2014
$358k
Testing feasibility of artemisinin-based synthetic-lethal suppression of skin phoR03CA167580 · NCI · UNIVERSITY OF ARIZONA · PI WONDRAK, GEORG T · 2012 to 2013
$152k
NCI NIH HHS CA023074NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA154377NCI NIH HHS R01CA154377NCI NIH HHS R03 CA167580NCI NIH HHS R21 CA166926NCI NIH HHS R21CA166926NIEHS NIH HHS 2R01ES015010NIEHS NIH HHS ES007091NIEHS NIH HHS ES06694NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R01 ES015010NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

The progressive nature of colorectal cancer and poor prognosis associated with the metastatic phase of the disease create an urgent need for the development of more efficacious strategies targeting colorectal carcinogenesis. Cumulative evidence suggests that the redox-sensitive transcription factor Nrf2 (nuclear factor-E2-related factor 2), a master regulator of the cellular antioxidant defence, represents a promising molecular target for colorectal cancer chemoprevention. Recently, we have identified cinnamon, the ground bark of Cinnamomum aromaticum (cassia cinnamon) and Cinnamomum verum (Ceylon cinnamon), as a rich dietary source of the Nrf2 inducer cinnamaldehyde (CA) eliciting the Nrf2-regulated antioxidant response in human epithelial colon cells, conferring cytoprotection against electrophilic and genotoxic insult. Here, we have explored the molecular mechanism underlying CA-induced Nrf2 activation in colorectal epithelial cells and have examined the chemopreventive potential of CA in a murine colorectal cancer model comparing Nrf2(+/+) with Nrf2(-/-) mice. In HCT116 cells, CA caused a Keap1-C151-dependent increase in Nrf2 protein half-life via blockage of ubiquitination with upregulation of cytoprotective Nrf2 target genes and elevation of cellular glutathione. After optimizing colorectal Nrf2 activation and target gene expression by dietary CA-supplementation regimens, we demonstrated that CA suppresses AOM/DSS-induced inflammatory colon carcinogenesis with modulation of molecular markers of colorectal carcinogenesis. Dietary suppression of colorectal cancer using CA supplementation was achieved in Nrf2(+/+) but not in Nrf2(-/-) mice confirming the Nrf2 dependence of CA-induced chemopreventive effects. Taken together, our data suggest feasibility of colorectal cancer suppression by dietary CA, an FDA-approved food additive derived from the third most consumed spice in the world.

Indexed as

AzoxymethaneDextran SulfateAcroleinAnimalsAnticarcinogenic AgentsCarcinogenesisChemopreventionCinnamomum zeylanicumColonic NeoplasmsCytoprotectionDietHCT116 CellsHumansMiceMice, Inbred C57BLMice, KnockoutAcroleinAnticarcinogenic AgentsAzoxymethanecinnamaldehydeDextran SulfateNF-E2-Related Factor 2

Identifiers

PMID25712056
PMCPMC4417412
OpenAlexW2146734738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.